The Genomic Atlas of Breast Cancer — the non-coding theme

Update News

  • GABC update 2020.06.15
  • GABC update 2019.03.20
  • GABC online 2018.08.09
  • Data collection 2018.04.09

About Us

  • Steven Xi Chen:
    steven.chen@miami.edu
  • Yunpeng Zhang:
    YXZ1418@med.miami.edu
  • Peng Wang:
    wpgqy@163.com
  • Shangwei Ning:
    ningsw@ems.hrbmu.edu.cn
  • Xia Li:
    lixia@hrbmu.edu.cn

Detail


Chr chr13
start 102394630
end 102395703
lncRNA name FGF14-AS2
entrez id 283481
hgnc id HGNC:44368
ensg id ENSG00000272143
refseq id NR_036487
methods qPCR, RIP etc.
regulated down-regulated
function description In this study, we demonstrated that FGF14 antisense RNA 2 (FGF14-AS2), a novel long non-coding RNA, was significantly down-regulated in breast cancer tissue compared with adjacent normal tissue both in validated cohort and TCGA cohort. Reduced expression of FGF14-AS2 was correlated with larger tumor size, more lymph node metastasis and advanced clinical stage in both cohorts.
pubmed id 26820525
year 2016
title A novel long non-coding RNA FGF14-AS2 is correlated with progression and prognosis in breast cancer.
drug X
circulating X
survival V

CopyRight © University of Miami, USA; Harbin Medical University, China